Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment
NCT06800599 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 7000
Last updated 2025-01-30
Summary
Single-centre, retrospective, prospective observational cohort study, based on the registration of data from users of the Oncology Genetics Outpatient Clinic
Conditions
- Genetic Predisposition to Cancer
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Principal Investigators
-
Daniela Turchetti, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-01
- Primary Completion
- 2037-12-31
- Completion
- 2037-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
NCT02302742 ·Status: RECRUITING
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
NCT05587439 ·Status: RECRUITING
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
NCT04494945 ·Status: RECRUITING ·Phase: NA
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Familial Cancer Registry and DNA Bank
NCT02083224 ·Status: UNKNOWN
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
NCT04920513 ·Status: COMPLETED
-
The Genetic Information and Family Testing (GIFT) Study
NCT05552664 ·Status: COMPLETED ·Phase: NA
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
The Registration Program of BRCA1/2 Gene
NCT02593435 ·Status: UNKNOWN
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Increasing Germline Genetic Testing for Patients With Cancer
NCT07307664 ·Status: RECRUITING ·Phase: NA
-
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
NCT04141462 ·Status: RECRUITING ·Phase: NA
-
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003329 ·Status: COMPLETED
-
Genetic Testing in Young Adults With Cancer Study
NCT04533555 ·Status: COMPLETED ·Phase: NA
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
NCT05759143 ·Status: RECRUITING ·Phase: NA
-
Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients
NCT04316507 ·Status: UNKNOWN ·Phase: NA
-
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00758173 ·Status: UNKNOWN
-
POA Retrospective Repository
NCT03326479 ·Status: UNKNOWN